Recurrent Intraocular Melanoma
The prognosis for any patient with recurring or relapsing disease is poor, regardless of cell type or stage. The question and selection of further treatment depends on many factors, including the extent of the lesion, age and health of the patient, prior treatment, and site of recurrence, as well as individual patient considerations. Clinical trials are appropriate and should be considered whenever possible.
Current Clinical Trials
Fashion Designer Marc Jacobs Launches Melanoma T-Shirt Campaign
Victoria Beckham did it. So did Heidi Klum, Julianne Moore, Eva Mendes, and Rufus Wainwright. To help raise money for skin cancer, these A-listers let themselves be photographed, naked, for fashion designer Marc Jacobs’ “Protect the Skin You’re In” melanoma naked T-shirt campaign. The celeb photos are featured on the T-shirts, which may be part of the reason why the initiative has so far brought in more than $500,000 for the NYU School of Medicine Interdisciplinary Melanoma Cooperative Group...
Read the Fashion Designer Marc Jacobs Launches Melanoma T-Shirt Campaign article > >
Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent intraocular melanoma. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
WebMD Public Information from the National Cancer Institute
Today in Melanoma
Health Solutions From Our Sponsors
©2005-2013 WebMD, LLC. All rights reserved.
WebMD does not provide medical advice, diagnosis or treatment. See additional information.